Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy.
Sign Up to like & getrecommendations! Published in 2019 at "Life sciences"
DOI: 10.1016/j.lfs.2019.116622
Abstract: AIMS This study was designed to compare the effects of empagliflozin monotherapy and its combination with metformin on glucose and lipid modulations in T2DM mice. MAIN METHODS Nine-week-old male C57BLKS/J db/db mice (n = 32) were used… read more here.
Keywords: empagliflozin monotherapy; glucose lipid; group; t2dm mice ... See more keywords